Cargando…
Efficacy of Azithromycin plus Glucocorticoid Adjuvant Therapy on Serum Inflammatory Factor Levels and Incidence of Adverse Reactions in Children with Mycoplasma Pneumonia
OBJECTIVE: This study was designed to explore the efficacy of azithromycin plus glucocorticoid adjuvant therapy on the levels of serum inflammatory factors and the incidence of adverse reactions in children with mycoplasma pneumonia. METHOD: A total of 90 eligible children with mycoplasma pneumonia...
Autores principales: | Cao, Yingdong, Dong, Binbin, Wang, Xuecheng, Wang, Chunrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001111/ https://www.ncbi.nlm.nih.gov/pubmed/35419069 http://dx.doi.org/10.1155/2022/1207512 |
Ejemplares similares
-
Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children
por: Han, Rui, et al.
Publicado: (2020) -
Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety
por: Li, Qiao, et al.
Publicado: (2019) -
A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia
por: Han, Li-ping, et al.
Publicado: (2021) -
Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum
por: Shi, Hongxing, et al.
Publicado: (2019) -
Tigecycline in the treatment of fulminant Mycoplasma pneumoniae pneumonia non-responsive to azithromycin and fluoroquinolone: A case report
por: Yuan, Xin, et al.
Publicado: (2020)